Ligand Pharmaceuticals Incorporated (LGND)

NGM – Real Time Price. Currency in USD

293.28

+4.53 (1.57%)

Market open: Aug 12, 2026, 11:58 AM EDT

288.75

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

06.08.2026

Ligand Pharmaceuticals Q2 Earnings Call Highlights

Ligand Pharmaceuticals NASDAQ: LGND reported second-quarter 2026 results marked by higher royalty revenue and adjusted earnings, while highlighting the post-quarter close of its XOMA Royalty acquisition and a $700 million zero-coupon convertible-note offering.

06.08.2026

Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call Transcript

Videos

No Data

There is no data to display

Ligand Pharmaceuticals Incorporated (LGND)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Q2 Earnings Call Highlights

Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call Transcript

Videos

No Data

Ligand Pharmaceuticals Q2 Earnings Call Highlights

Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call Transcript

Videos

No Data

Search stocks

Ligand Pharmaceuticals Incorporated (LGND)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Ligand Pharmaceuticals Incorporated (LGND)

Ligand Pharmaceuticals Q2 Earnings Call Highlights

Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call Transcript

Videos

No Data

Ligand Pharmaceuticals Q2 Earnings Call Highlights

Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call Transcript

Videos

No Data